Myeloperoxidase Monoclonal Antibody (MPO mAb)
Myeloperoxidase (MPO) is a 150 kDa peroxidase enzyme found predominantly in neutrophil granulocytes. It consists of two light chains (15 kDa) and two variable-weight glycosylated heavy chains (60kDa) bound to a prosthetic heme group. Myeloperoxidase plays the key role in antimicrobial oxygen-dependent activity of neutrophils.
In diagnostics it has been shown to be of use to predict myocardial infarction (Brennan et al, 2003). Unlike other established cardiac markers, such as Troponin T, CK MB and CRP, MPO levels pinpointed high risk cardiac patients in the absence of myocardial necrosis. At the moment MPO is under consideration as one of the most promising cardiac markers. In addition, MPO staining is important in the diagnosis of extramedullary leukemia (chloroma).
SCIPAC offer MPO antibodies with high affinity to native as well as recombinant human MPO in ELISA as well as Western Blot format.